Arcutis Biotherapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Frazier Life Sciences and affiliated entities updated their beneficial ownership in Arcutis Biotherapeutics, Inc. via an Amendment No. 7 to their Schedule 13D.